U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06960044) titled 'Procalcitonin Aided Antimicrobial Therapy vs Standard of Care' on April 24.
Brief Summary: Antibiotic resistance is driven by overuse, especially for viral respiratory infections. Procalcitonin (PCT), a biomarker for bacterial infections, helps guide antibiotic therapy more precisely, reducing unnecessary use and improving outcomes. Studies, including large trials and economic models across several countries, show PCT-guided treatment lowers mortality, antibiotic exposure, therapy duration and related complications, potentially reducing hospital costs despite initial testing expenses.
Study Start Date: June 01
Study Type: INTERVENTI...